Human Glutamate Transporter Structure
Human Glutamate Transporter Structure
批准号:
8699001
负责人:
MICHAEL PATRICK KAVANAUGH
金额:
$28.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2018-06-30
关键词:
AffinityAlkaliesAlzheimer&aposs DiseaseAmino Acid TransporterBrainBuffersCationsCellsChronicCoupledCrystallizationCrystallographyDetectionDetergentsDevelopmentDiagnosticDiffusionDisulfidesEAAT3EngineeringExcitatory Amino AcidsFab ImmunoglobulinsFluorescenceFrequenciesFunctional disorderGlutamate TransporterGlutamatesGoalsHomologous GeneHumanImageImpairmentInjuryInsectaIonsLigandsLipidsMediatingMetabolicMolecular ConformationMolecular Sieve ChromatographyMutagenesisNeuraxisNeuronsNeurotransmittersOxidantsPathologyPharmaceutical PreparationsPhysiologyPlayPositioning AttributeProteinsReagentResearchResolutionRoleSignal TransductionStrokeStructureSurfaceSynapsesTestingTherapeuticTimeTraumatic Brain InjuryWorkX-Ray Crystallographycrosslinkdensityexcitotoxicitymutantneuron losspostsynapticpresynapticpreventpublic health relevancereceptorreuptakescreeninguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Glutamate is the primary excitatory neurotransmitter in the mammalian central nervous system. Glutamate is released by presynaptic neurons and signals primarily through postsynaptic ionotropic and metabotropic receptors. Excitatory amino acid transporters (EAATs) play critical roles in neuronal physiology and pathophysiology. In order for high frequency signaling to occur, neurotransmitter must be removed from the synapse soon after release. Additionally, low levels of ambient glutamate are required to prevent chronic excitotoxic activity of high-affinity receptors. In pathological circumstances, changes in glutamate transporter function and/or surface density can occur. Disruption of alkali ion gradients caused by metabolic impairment after stroke or traumatic brain injury cause transporter slowing or reversal, contributing to glutamate elevation and excitotoxicity. Bidirectional changes in transporter surface expression occur in both normal and pathophysiological conditions, causing ambient glutamate levels to change. Development of selective new ligands for modulating and imaging glutamate transporter density changes is an important goal. We propose to determine the first high-resolution atomic structure of a human neuronal glutamate transporter. This will provide new understanding of transporter function and facilitate development of selective and high- affinity EAAT ligands for potential therapeutic and diagnostic uses.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0156551
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Foster AC, Farnsworth J, Lind GE, Li YX, Yang JY, Dang V, Penjwini M, Viswanath V, Staubli U, Kavanaugh MP]
通讯作者:
Kavanaugh MP
Novel dicarboxylate selectivity in an insect glutamate transporter homolog.
昆虫谷氨酸转运蛋白同系物中的新型二羧酸选择性。
DOI:
10.1371/journal.pone.0070947
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Wang,Hui, Rascoe,AviM, Holley,DavidC, Gouaux,Eric, Kavanaugh,MichaelP]
通讯作者:
Kavanaugh,MichaelP
Homeostatic control of the NMDA receptor co-agonist D-serine by SLC1A4
-
批准号:9890859
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2018
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
The Big Sky Brain Project
-
批准号:8715756
-
项目类别:
-
资助金额:$25.64万
-
财政年份:2011
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
The Big Sky Brain Project
-
批准号:8909096
-
项目类别:
-
资助金额:$23.06万
-
财政年份:2011
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
The Big Sky Brain Project
-
批准号:8328909
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2011
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
High-Level Expression of Human EAAT3 for Biochemical and Structural Analysis
-
批准号:8035863
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2011
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
High-Level Expression of Human EAAT3 for Biochemical and Structural Analysis
-
批准号:8315947
-
项目类别:
-
资助金额:$6.07万
-
财政年份:2011
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
The Big Sky Brain Project
-
批准号:8257059
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2011
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
The Big Sky Brain Project
-
批准号:8517072
-
项目类别:
-
资助金额:$23.71万
-
财政年份:2011
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
CENTER FOR STRUCTURAL AND FUNCTIONAL NEUROSCIENCE
-
批准号:7894204
-
项目类别:
-
资助金额:$47.22万
-
财政年份:2009
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
CENTER FOR STRUCTURAL AND FUNCTIONAL NEUROSCIENCE
-
批准号:7919846
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2009
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
MT COBRE: ADMINISTRATIVE CORE
-
批准号:7959446
-
项目类别:
-
资助金额:$40.11万
-
财政年份:2009
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
CSFN PILOT SUBPROJECTS
-
批准号:7959454
-
项目类别:
-
资助金额:$16.13万
-
财政年份:2009
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
MT COBRE: CORE FACILITY DEVELOPMENT
-
批准号:7959448
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2009
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
RECRUIT #4: COLLEGE OF ARTS & SCIENCES
-
批准号:7959455
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2009
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
MT COBRE: CNS GLUTAMATE AND GLUTAMINE TRANSPORT: A MULTIDISCIPLINARY APPROACH
-
批准号:7720404
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2008
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
Characterization and Use of Fluorescent Endocannabinoid Transporter Substrates
-
批准号:7590454
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2008
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
Characterization and Use of Fluorescent Endocannabinoid Transporter Substrates
-
批准号:7460466
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2008
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
Characterization and Use of Fluorescent Endocannabinoid Transporter Substrates
-
批准号:7850419
-
项目类别:
-
资助金额:$1.82万
-
财政年份:2008
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
MT COBRE: CNS GLUTAMATE AND GLUTAMINE TRANSPORT: A MULTIDISCIPLINARY APPROACH
-
批准号:7609803
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2007
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
MT COBRE: CNS GLUTAMATE AND GLUTAMINE TRANSPORT: A MULTIDISCIPLINARY APPROACH
-
批准号:7381175
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2006
-
负责人:MICHAEL PATRICK KAVANAUGH
-
依托单位:
海外基金